What Fucidin Ointment Treats: Main Uses and Benefits

The medicine is commonly used in the treatment of localized skin infections caused by bacteria sensitive to the active ingredient, sodium fusidate. This topical agent is primarily applied to manage the symptomatic manifestations of bacterial growth, contributing to support during acute or episodic changes.

Therapeutic Focus and Relief

This antibacterial preparation is considered relevant across two therapeutic areas: primary bacterial skin infections and secondary infection in compromised skin. Primary infections include impetigo contagiosa, folliculitis, sycosis barbae, and erythrasma. It is also relevant in scenarios where the skin barrier is already breached, such as infected eczema, infected contact dermatitis, or superficial cuts and burns. By managing the localized bacterial activity, the ointment helps reduce associated inflammatory symptoms and may assist with the management of the affected area.

“This treatment is often applied in settings where localized symptomatic assistance is needed due to bacterial presence.”

The primary practical benefit, focused on localized infection control, is associated with symptomatic relief. It is used to address the active, distressing manifestations of infection, easing the redness, swelling, and purulent discharge. This action supports general well-being and comfort, particularly when the infection is superficial and mild to moderately severe.

---

Quick Fact: Relief for Localized Infection
Fucidin Ointment is considered relevant for managing bacterial skin infections when symptoms cluster into patterns of weeping, crusting, and localized redness.

Official Eligibility Status for Fucidin Ointment

Contraindicated Populations The medicine is strictly contraindicated for any individual with a known hypersensitivity to the active substance, Fusidic Acid (Sodium Fusidate), or to any of the excipients within the ointment formulation, such as cetyl alcohol, lanolin, or butylhydroxytoluene (E321). This constitutes the primary absolute non-eligibility rule.

Age and Life Stage Eligibility Fucidin Ointment is permitted for use across the entire age spectrum, including adults, older adults, and the pediatric population. Use is also permitted during pregnancy and breastfeeding as systemic absorption following topical application is considered negligible.

Eligibility Restrictions Certain conditional use rules apply:

1. Application Site: The ointment must be used with care to avoid contact with the eyes due to the potential for local irritation from the excipients.
2. Lactation: Although permitted, application directly onto the breast should be avoided during breastfeeding to prevent accidental ingestion by the infant.
3. Systemic Risk: Caution is advised when applying the ointment to large body surface areas or under occlusive dressings (especially in infants), which may increase the already minimal systemic absorption. No specific eligibility restrictions are documented for patients with renal or hepatic impairment for the topical formulation.

Interaction Map: Interactions with other medicines and products — official regulatory information for Fucidin Ointment

---

Interaction scope

The official interaction profile for Fucidin Ointment (topical sodium fusidate) is defined by the regulatory determination of minimal systemic exposure. Due to the negligible systemic absorption, regulatory agencies state that no drug-drug interaction studies have been performed for the topical formulation. Consequently, no specific medicinal products or product categories are documented to interact with the ointment, and no mechanistic basis for systemic interaction (such as CYP enzyme effects or transporter issues) is officially listed in the product labeling. There are no timing-based administration rules, separation requirements, or population-specific interaction notes included in the regulatory documentation.

---

Interaction classifications (high-level)

Property	Official Regulatory Documentation
Interaction severity classification (as defined in official documents)	Minimal/None Known
Interaction-context constraints (as defined in official documents)	Interactions with systemically administered products are considered minimal due to the negligible systemic absorption of the topical ointment.

---

Resulting interaction structure

The official interaction profile is characterized by the absence of known or studied drug-drug, drug-food, or drug-substance interactions for the topical product. The regulatory documents explicitly state that interactions with systemically administered medicinal products are considered minimal. This establishes the product's official interaction structure as free from mandatory co-administration restrictions, timing constraints, or interaction-related prohibitions specified in the official labeling.

How Fucidin Ointment Works: Mechanism of Action

The action of Fusidic Acid, the active component in Fucidin Ointment, is defined by its selective and targeted interference with the growth mechanisms of susceptible bacteria.

---

Targeted Inhibition of Bacterial Protein Synthesis

Fusidic Acid functions as a highly specific inhibitor of bacterial Elongation Factor G ( EF-G), an enzyme essential for the movement of the 70S ribosome during the protein synthesis elongation phase. By binding to and stabilizing the EF-G-ribosome complex, the drug locks the machinery in a non-functional state, instantly halting the assembly line for all new bacterial proteins.

---

Mechanistic Cascade: Arresting Microbial Proliferation

The complete cessation of protein synthesis prevents the targeted bacteria from growing, multiplying, or dividing, which is the definition of a bacteriostatic effect. This arrest of microbial proliferation is the fundamental physiological step resulting from the bacteriostatic effect. The high selectivity for the prokaryotic target minimizes interaction with the analogous human eukaryotic process.

---

Limitations via Acquired Resistance

This inhibitory mechanism can be constrained when bacteria develop acquired resistance either through chromosomal mutations that alter the EF-G binding site, or through the acquisition of plasmid-encoded proteins (like FusB or FusC) that actively counteract the inhibitory lock, allowing the ribosome to resume its function.

How to Use Fucidin Ointment

This section outlines the usage principles for Fucidin Ointment (containing Sodium Fusidate 20 mg/g).

---

Administration Scope

Feature	Guideline
Route of administration	Topical use only; intended for cutaneous use.
Dosing schedule	Apply a small amount to the affected area.
Age-group administration	The same frequency regimen is generally followed by both the Adults and Paediatric Population.

---

Frequency and Course Duration

Classification	Detail
Frequency pattern (Uncovered)	Typically two to three times daily.
Frequency pattern (Covered)	One application daily may be sufficient if an occlusive dressing is used.
Course duration	The average treatment period is seven days (7 days). The full prescribed course should be completed.

---

Administration Instructions

The frequency of application is determined by whether a covering dressing is utilized. When applying, gently rub a small amount into the skin. When treating impetigo, it is not necessary to remove any crusts before applying the ointment. Following application, standard procedure is to wash hands thoroughly, unless the hands are the area being treated. Care must also be taken to avoid the eyes when applying the ointment to the face. The instructions establish a standard, time-bound protocol for external use of the medicine.

Evidence for Use in Impetigo Contagiosa

The primary research for Fucidin Ointment, particularly for impetigo, consists of Randomized Controlled Trials (RCTs) and systematic reviews that summarize findings across multiple studies. These trials were evaluated in both adult and pediatric populations, including children aged two years and older. Researchers examined specific outcomes related to physical discomfort, such as the overall clinical cure status (resolution of lesions) and the bacteriological status (pathogen eradication). The research generally highlights measured changes observed during the study period, providing context on how patient experiences were captured during the acute phase.

---

Evidence for Other Superficial Skin Infections

The ointment was also studied for a broader range of superficial bacterial skin infections, such as folliculitis or secondarily infected conditions like eczema. This research includes comparative clinical trials and various open-label studies. These studies monitored outcomes reflecting overall clinical response and healing time, often describing patterns in short-term symptom evolution. The quality and type of evidence for these secondary indications varies across studies compared to the core impetigo research.

---

Comparative Research and Placebo Trials

Clinical research involved comparisons against non-active controls (placebo) to understand the context of the observed changes. Additionally, numerous studies explored the ointment's usage alongside other existing topical antibiotic treatments. These studies measured how symptom change over time was tracked in groups receiving different medications, and the research provides context on the short-term measured changes.

---

Research Gaps and Uncertainties

The primary research was evaluated in children and general adults; however, data for certain groups remain insufficient. For instance, there is limited information for older adults or individuals with complex comorbidities. Furthermore, the duration of follow-up in most trials was short-term, typically ranging from 7 to 25 days, meaning the long-term effects are not fully established. Research is also ongoing to fully understand the clinical impact of patterns of bacterial resistance that may be observed in common skin pathogens.

Key Studies & References

1. Impetigo: antimicrobial prescribing (NG153) - Recommendations and considerations

Common questions about Fucidin Ointment (FAQ)

Q: Is Fucidin Ointment the same as Fucidin Cream?

A: The ointment and cream contain the same active ingredient, fusidic acid (or sodium fusidate). However, they are different formulations because they contain different non-active ingredients, or excipients. This difference in base can affect the consistency and how the product is applied to the skin.

---

Q: Can Fucidin Ointment be used on the face?

A: Fucidin Ointment can be used on the face. However, official product information emphasizes avoiding contact with the eyes when applying, as the excipients in the ointment can cause irritation to the conjunctiva (the lining of the eyelids and eyeball).

---

Q: Can Fucidin Ointment be used for minor cuts or scrapes?

A: Official indications state that the ointment is for treating primary and secondary skin infections, which includes cases like infected cuts. The product is not specifically indicated for use on minor cuts or scrapes that are not infected. The suitability for any specific wound is typically determined by a healthcare provider.

---

Q: Is it common for Fucidin Ointment to be prescribed for impetigo?

A: Regulatory documents explicitly list Fucidin Ointment as a treatment for primary skin infections, specifically including impetigo contagiosa. It is explicitly listed as a primary indication for which the product is used.

---

Q: Can Fucidin Ointment be used for eczema?

A: Fucidin Ointment is indicated for treating secondary skin infections, which includes conditions like infected eczematoid dermatitis (infected eczema). It is not indicated for treating uninfected eczema itself, as the drug only targets bacteria.

---

Q: Does Fucidin Ointment treat fungal infections?

A: No, Fucidin Ointment is classified as a topical antibacterial agent (an antibiotic) that is effective only against susceptible bacteria, such as Staphylococci. Official information confirms that it is not effective against fungal or viral infections.

---

Q: Is Fucidin Ointment available without a prescription in some countries?

A: Regulatory classification in many regions, including the UK and Australia, is Prescription Only Medicine (POM), meaning it requires a prescription from a healthcare professional to be dispensed. Availability without a prescription is not supported by official labeling in these key regions.

---

Q: Can Fucidin Ointment be used on open wounds?

A: Official regulatory documents state the ointment is indicated for certain skin and wound infections. However, related product information (such as for the combination product Fucidin H) may advise caution or avoidance on fresh open wounds. The suitability for use on a specific wound is typically determined by a healthcare provider.

---

Q: Does Fucidin Ointment cause skin discoloration?

A: Official regulatory documents for Fucidin Ointment (fusidic acid only) do not list skin discoloration or depigmentation as an adverse effect. This type of skin change is listed as a known adverse effect only for the corticosteroid component found in related combination products.

---

Q: Can Fucidin Ointment be used on the lips or near the mouth?

A: The excipient butylhydroxytoluene (E321), contained within the ointment, may cause irritation to mucous membranes (such as the lips or genital area). Official warnings advise avoiding application to or near these areas.

---

Q: What is the risk of resistance when using Fucidin Ointment, according to research?

A: Regulatory warnings state that bacterial resistance to fusidic acid has been reported to occur with its use. As with all antibiotics, extended or recurrent use of the ointment may increase the risk of developing resistance in the bacteria it is designed to treat.

---

Q: Are there any known interactions between Fucidin Ointment and specific clothing materials or bandages?

A: Official product warnings include a safety hazard about fire risk. Fabric (such as clothing, bedding, or dressings) that has been in contact with the ointment burns more easily and is considered a serious fire hazard. This increased flammability risk persists even after washing.

---

Q: What is the official distinction between Fucidin and Fucidin H?

A: Fucidin Ointment contains only the antibiotic fusidic acid (sodium fusidate). Fucidin H is a different combination product that contains the antibiotic fusidic acid plus a corticosteroid (hydrocortisone acetate).

---

Q: Do official sources list any foods or drinks that interact with Fucidin Ointment?

A: Due to its function as a topical product with negligible absorption into the body, official regulatory documents do not list any specific food or drink interactions for Fucidin Ointment.

---

Q: Are there studies examining Fucidin Ointment's use in combination with topical corticosteroids?

A: The manufacturer produces and regulates combination products like Fucidin H (with hydrocortisone) which contain the same fusidic acid component along with a corticosteroid. The existence of these products confirms that the combination of fusidic acid with steroids is a regulated formulation.

---

Q: Is Fucidin Ointment the same drug as the oral tablets?

A: The active ingredient is the same (fusidic acid or sodium fusidate). However, the two products are different dosage forms. The ointment is a topical product meant only for application to the skin, while the tablet is a systemic product designed to be taken by mouth and absorbed throughout the body.

---

Q: Does Fucidin Ointment contain a preservative that could irritate sensitive skin?

A: The ointment contains excipients such as cetyl alcohol, wool fat (lanolin), and butylhydroxytoluene (E321). Official product information notes that these substances may cause local skin reactions, such as contact dermatitis, in sensitive individuals.

---

Q: Are there any groups of people officially designated as high-risk for using Fucidin Ointment?

A: Individuals with a known hypersensitivity to fusidic acid or any of the excipients are contraindicated from using the product. Caution is also advised for people with certain immune deficiencies, such as those who have undergone a stem cell transplant.

Storage and Disposal of Fucidin Ointment

Storage Conditions

Fucidin Ointment must be stored in a cool, dry place and protected from heat and dampness. Depending on the formulation, the storage requirement is either store below 30°C or no special storage conditions in the unopened container.

Critically, the medicine must be kept out of the sight and reach of children.

Stability and Expiry

Do not use the product after the expiry date (EXP) printed on the packaging. Once the tube is opened, the medicine has a limited post-opening life; it must be discarded 3 months after first opening (some labels specify 60 days).

Disposal Instructions

Unused or expired Fucidin Ointment must not be disposed of via wastewater or household waste. To ensure environmental protection, patients must ask their pharmacist how to safely throw away medicines they no longer need.